378 related articles for article (PubMed ID: 32497711)
41. Itch and eczema.
Darsow U; Pfab F; Valet M; Tölle TR; Ring J
Chem Immunol Allergy; 2012; 96():81-88. PubMed ID: 22433375
[TBL] [Abstract][Full Text] [Related]
42. Pruritus in Autoimmune and Inflammatory Dermatoses.
Zeidler C; Pereira MP; Huet F; Misery L; Steinbrink K; Ständer S
Front Immunol; 2019; 10():1303. PubMed ID: 31293565
[TBL] [Abstract][Full Text] [Related]
43. Pruritus in Black Skin: Unique Molecular Characteristics and Clinical Features.
McColl M; Boozalis E; Aguh C; Eseonu AC; Okoye GA; Kwatra SG
J Natl Med Assoc; 2021 Feb; 113(1):30-38. PubMed ID: 32747312
[TBL] [Abstract][Full Text] [Related]
44. Pathophysiology and therapy of pruritus in allergic and atopic diseases.
Buddenkotte J; Steinhoff M
Allergy; 2010 Jul; 65(7):805-21. PubMed ID: 20384615
[TBL] [Abstract][Full Text] [Related]
45. Itch: From mechanism to (novel) therapeutic approaches.
Yosipovitch G; Rosen JD; Hashimoto T
J Allergy Clin Immunol; 2018 Nov; 142(5):1375-1390. PubMed ID: 30409247
[TBL] [Abstract][Full Text] [Related]
46. Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis.
Fujii M; Takeuchi K; Umehara Y; Takeuchi M; Nakayama T; Ohgami S; Asano E; Nabe T; Ohya S
Eur J Pharmacol; 2018 Oct; 836():57-66. PubMed ID: 30125561
[TBL] [Abstract][Full Text] [Related]
47. Pathophysiologic mechanisms of itch in bullous pemphigoid.
Hashimoto T; Kursewicz CD; Fayne RA; Nanda S; Shah SM; Nattkemper L; Yokozeki H; Yosipovitch G
J Am Acad Dermatol; 2020 Jul; 83(1):53-62. PubMed ID: 31351883
[TBL] [Abstract][Full Text] [Related]
48. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
49. Itch in atopic dermatitis - pathophysiology and treatment.
Ständer S; Luger TA
Acta Dermatovenerol Croat; 2010; 18(4):289-96. PubMed ID: 21251449
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
Nakashima C; Otsuka A; Kabashima K
Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
[TBL] [Abstract][Full Text] [Related]
51. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
[No Abstract] [Full Text] [Related]
52. Possible roles of basophils in chronic itch.
Hashimoto T; Rosen JD; Sanders KM; Yosipovitch G
Exp Dermatol; 2019 Dec; 28(12):1373-1379. PubMed ID: 29894005
[TBL] [Abstract][Full Text] [Related]
53. Itching at night: A review on reducing nocturnal pruritus in children.
Boozalis E; Grossberg AL; Püttgen KB; Cohen BA; Kwatra SG
Pediatr Dermatol; 2018 Sep; 35(5):560-565. PubMed ID: 29943835
[TBL] [Abstract][Full Text] [Related]
54. Correlation of serum interleukin-31 with pruritus and blood eosinophil markers in children with atopic dermatitis.
Byeon JH; Yoon W; Ahn SH; Lee HS; Kim S; Yoo Y
Allergy Asthma Proc; 2020 Jan; 41(1):59-65. PubMed ID: 31888784
[No Abstract] [Full Text] [Related]
55. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
56. Itch in Atopic Dermatitis.
Kido-Nakahara M; Furue M; Ulzii D; Nakahara T
Immunol Allergy Clin North Am; 2017 Feb; 37(1):113-122. PubMed ID: 27886901
[TBL] [Abstract][Full Text] [Related]
57. Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis.
Haddad EB; Cyr SL; Arima K; McDonald RA; Levit NA; Nestle FO
Dermatol Ther (Heidelb); 2022 Jul; 12(7):1501-1533. PubMed ID: 35596901
[TBL] [Abstract][Full Text] [Related]
58. Emerging small-molecule compounds for treatment of atopic dermatitis: a review.
Vávrová K
Expert Opin Ther Pat; 2016; 26(1):21-34. PubMed ID: 26470599
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory mediators causing cutaneous chronic itch in some diseases via transient receptor potential channel subfamily V member 1 and subfamily A member 1.
Xie B; Li XY
J Dermatol; 2019 Mar; 46(3):177-185. PubMed ID: 30588658
[TBL] [Abstract][Full Text] [Related]
60. Pruritic dermatoses: overview of etiology and therapy.
Charlesworth EN; Beltrani VS
Am J Med; 2002 Dec; 113 Suppl 9A():25S-33S. PubMed ID: 12517579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
